HUM vs INNV
HUM: A prominent managed care organization and provider of Medicare Advantage insurance plans. INNV: InnovAge provides comprehensive, capitated, all-inclusive healthcare for frail seniors through its network of PACE centers.
Side-by-side fundamentals
| Metric | HUM | INNV | Edge |
|---|---|---|---|
| Price as of 2026-10-20 close | $427.38 | $9.15 | |
| Market cap | $51.3B | $1.2B | |
| P/E as of 2026-10-20 | 45.61 | n/a | |
| Net margin | +0.9% | -0.3% | HUM higher |
| Gross margin FY2026, SEC XBRL | n/a | +23.0% | |
| Operating margin | +2.1% | +0.3% | HUM higher |
| ROE | +6.7% | -1.1% | HUM higher |
| ROA | +2.4% | -0.5% | HUM higher |
| Debt / equity | 0.75 | 0.20 | INNV lower |
| Revenue growth (YoY) | +10.1% | +15.9% | INNV higher |
| Revenue CAGR (3y) SEC XBRL | +11.8% | +12.9% | INNV higher |
| Dividend yield as of 2026-09-03 | +0.9% | n/a | |
| Dividend streak (yrs) SEC XBRL | 15 | 0 | HUM higher |
| Beta as of 2026-09-03 | 0.48 | 1.05 | |
| 1-year return as of 2026-10-20 close | +50.5% | +71.0% | INNV higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-20.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.